Electrification And Supply Chain Realignment Will Support Long Duration High Reliability Electronics Programs

Catalysts

About Cyient DLM

Cyient DLM provides high reliability electronics manufacturing and design led build to spec solutions across aerospace, defense, industrial, medical and transportation end markets.

What are the underlying business or industry changes driving this perspective?

• Robust order intake with a Q3 FY '26 book to bill of 1.3 and year to date book to bill of 1.56, along with an order book of INR 23.5b, points to strong delivery visibility that can support steadier revenue recognition and potentially smoother earnings over the next several quarters.
• Electrification and digitization across transportation, industrial systems, energy and devices are increasing electronics content and the need for high reliability partners. This can support higher value programs for Cyient DLM and, over time, a larger revenue base and more resilient gross margins.
• Global supply chain realignment and OEM derisking, with India emerging as a credible manufacturing base, are driving more high complexity, mission critical work towards the company. This can help sustain the order pipeline and support operating leverage benefits at the EBITDA level.
• Early involvement in next generation product development for four anchor customers across transportation, industrial and defense, along with build to spec and platform investments, creates long duration programs that can lift future revenue while supporting structurally better gross margins and earnings quality.
• The shift in mix towards automotive, industrial and medical, combined with a growing share of box build, mechanical and other value added services, is contributing to a healthier margin profile, which is already visible in double digit EBITDA margins and may support more stable PAT margins as scale improves.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more optimistic perspective on Cyient DLM compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
• The bullish analysts are assuming Cyient DLM's revenue will grow by 25.6% annually over the next 3 years.
• The bullish analysts assume that profit margins will increase from 6.1% today to 7.4% in 3 years time.
• The bullish analysts expect earnings to reach ₹2.0 billion (and earnings per share of ₹24.94) by about July 2029, up from ₹821.0 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as ₹1.6 billion.
• In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 49.2x on those 2029 earnings, down from 67.5x today. This future PE is greater than the current PE for the IN Electronic industry at 31.5x.
• The bullish analysts expect the number of shares outstanding to grow by 0.06% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 15.17%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Revenue is currently concentrated in complex, often lumpy programs, as seen with the completion of a large cyclical order in FY '25 that coincided with a 31.7% year on year revenue decline in Q3 FY '26. If future program wins or renewals are delayed or smaller than expected, overall revenue and earnings could remain volatile rather than trending higher.
• The company is leaning into long cycle areas like aerospace, defense, industrial and medical. If sector level spending slows, programs are scaled back, or new build to spec engagements for next generation products do not ramp as expected from FY '28, order intake and the assumed uplift in gross and EBITDA margins could come under pressure.
• Tariff and trade policy risk around shipments from India to the US, including the current 50% tariff discussion, may persist or worsen. If proposed workarounds do not fully offset the cost for customers or require shifting production footprints, this could weigh on US bound revenue and compress net margins.
• Working capital intensity is elevated, with higher days inventory outstanding driven by shipment delays and inventory buildup for Q4. If this pattern continues rather than easing, it could constrain cash generation, increase reliance on external funding and weigh on net profit due to higher financing or operational costs.
• The growth plan relies on expanding sales teams, scaling build to spec, adding new geographies and pursuing inorganic growth. If integration of acquisitions, new capacity or new customer wins is slower or less profitable than intended, operating leverage might not materialize as expected, affecting EBITDA margins and earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bullish price target for Cyient DLM is ₹800.0, which represents up to two standard deviations above the consensus price target of ₹568.5. This valuation is based on what can be assumed as the expectations of Cyient DLM's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹800.0, and the most bearish reporting a price target of just ₹350.0.
• In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be ₹26.8 billion, earnings will come to ₹2.0 billion, and it would be trading on a PE ratio of 49.2x, assuming you use a discount rate of 15.2%.
• Given the current share price of ₹698.15, the analyst price target of ₹800.0 is 12.7% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.